Literature DB >> 29152559

Fasciola hepatica ESPs Could Indistinctly Activate or Block Multiple Toll-Like Receptors in a Human Monocyte Cell Line.

Olgary Figueroa-Santiago1, Ana M Espino1.   

Abstract

Fasciola hepatica is a parasitic helminth that induces Th2/Treg responses in its mammalian host. Some reports have suggested that ESPs achieve these polarized immune responses by delaying the activation of dendritic cells and macrophages during the early stages of innate immunity, a process that is mediated by TLR4. The present study aimed to investigate whether TLRs other than TLR4 could also be targeted by F. hepatica ESPs. To achieve this aim a screening system was optimized using THP1-Blue CD14 cells. ESPs were first separated based on their molecular weight and according their net charge by ion exchange chromatography (IEC). Results demonstrated that F. hepatica ESPs mainly cathepsin, serpin and endopin are capable of activating TLR2, TLR4, TLR8 and likely also TLR5 and TLR6. In contrast, fatty acid binding protein strongly suppressed the stimulation induced by various TLR-ligands. Further studies are needed to understand how these apparent contradictory effects of molecules of the same protein mix complement each other in the context of an active infection resulting in the polarized Th2-immune response that characterize F. hepatica infections.

Entities:  

Keywords:  Excretory-secretory products; Fasciola hepatica; Fatty acid binding protein; Innate immunity; Toll-like receptors

Year:  2017        PMID: 29152559      PMCID: PMC5690573     

Source DB:  PubMed          Journal:  Ann Clin Pathol        ISSN: 2373-9282


  42 in total

Review 1.  Novel secretory vesicle serpins, endopin 1 and endopin 2: endogenous protease inhibitors with distinct target protease specificities.

Authors:  Vivian Y H Hook; Shin-Rong Hwang
Journal:  Biol Chem       Date:  2002 Jul-Aug       Impact factor: 3.915

Review 2.  Novel chromaffin granule serpins, endopin 1 and endopin 2: endogenous protease inhibitors with distinct target protease specificities.

Authors:  Vivian Y H Hook; Sukkid Yasothornsrikul; Shin-Rong Hwang
Journal:  Ann N Y Acad Sci       Date:  2002-10       Impact factor: 5.691

3.  Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages.

Authors:  Sheila Donnelly; Sandra M O'Neill; Mary Sekiya; Grace Mulcahy; John P Dalton
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Experimental Fasciola hepatica infection alters responses to tests used for diagnosis of bovine tuberculosis.

Authors:  Robin J Flynn; Celine Mannion; Olwen Golden; Orcun Hacariz; Grace Mulcahy
Journal:  Infect Immun       Date:  2006-12-28       Impact factor: 3.441

5.  Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4.

Authors:  Amy R Weatherill; Joo Y Lee; Ling Zhao; Danielle G Lemay; Hyung S Youn; Daniel H Hwang
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

Review 6.  Epidemiology of human fascioliasis: a review and proposed new classification.

Authors:  M S Mas-Coma; J G Esteban; M D Bargues
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

7.  Excretory/secretory proteome of the adult stage of Echinostoma caproni.

Authors:  Javier Sotillo; M Luz Valero; Manuel M Sánchez Del Pino; Bernard Fried; J Guillermo Esteban; Antonio Marcilla; Rafael Toledo
Journal:  Parasitol Res       Date:  2010-05-29       Impact factor: 2.289

Review 8.  Helminth vaccines: from mining genomic information for vaccine targets to systems used for protein expression.

Authors:  John P Dalton; Paul J Brindley; Dave P Knox; Ciaran P Brady; Peter J Hotez; Sheila Donnelly; Sandra M O'Neill; Grace Mulcahy; Alex Loukas
Journal:  Int J Parasitol       Date:  2003-05       Impact factor: 3.981

9.  Early and late peritoneal and hepatic changes in goats immunized with recombinant cathepsin L1 and infected with Fasciola hepatica.

Authors:  R Zafra; R A Pérez-Écija; L Buffoni; P Moreno; M J Bautista; A Martínez-Moreno; G Mulcahy; J P Dalton; J Pérez
Journal:  J Comp Pathol       Date:  2012-10-16       Impact factor: 1.311

10.  Fasciola hepatica fatty acid binding protein induces the alternative activation of human macrophages.

Authors:  Olgary Figueroa-Santiago; Ana M Espino
Journal:  Infect Immun       Date:  2014-09-15       Impact factor: 3.441

View more
  3 in total

1.  Possible Role for Toll-Like Receptors in Interaction of Fasciola hepatica Excretory-Secretory Products with Human Monocyte Cell Line.

Authors:  Olgary Figueroa-Santiago; Ana Espino
Journal:  Methods Mol Biol       Date:  2020

2.  Fasciola hepatica Cathepsin L Zymogens: Immuno-Proteomic Evidence for Highly Immunogenic Zymogen-Specific Conformational Epitopes to Support Diagnostics Development.

Authors:  Clare F Collett; Helen C Phillips; Maggie Fisher; Sian Smith; Caroline Fenn; Phil Goodwin; Russell M Morphew; Peter M Brophy
Journal:  J Proteome Res       Date:  2022-07-18       Impact factor: 5.370

3.  Immune response to recombinant Burkholderia pseudomallei FliC.

Authors:  Sirikamon Koosakulnirand; Phornpun Phokrai; Kemajittra Jenjaroen; Rosemary A Roberts; Pongsak Utaisincharoen; Susanna J Dunachie; Paul J Brett; Mary N Burtnick; Narisara Chantratita
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.